mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.3 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.3 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |